Oestrogen Receptor-Mediated Modulation of the EGFR/MAPK Pathway in Tamoxifen-Resistant MCF-7 Cells

By Hutcheson I.R.  

Breast Cancer Research and Treatment, Vol. 81, Iss. 1, 2003-09 ,pp. : 81-93

Springer Publishing Company

Access to resources Recommend Favorite

NGX6 expression improves the sensitivity of tamoxifen-resistant MCF-7 cells through modulation of the Smad signaling pathway

By    

International Journal of Oncology, Vol. 42, Iss. 6, 2013-01 ,pp. : 2060-2068

Spandidos Publications

Access to resources Recommend Favorite

Activation of mitogenic pathways and sensitization to estrogen-induced apoptosis: two independent characteristics of tamoxifen-resistant breast cancer cells?

By Scherbakov Alexander   Lobanova Yulia   Shatskaya Valentina   Onopchenko Oksana   Gershtein Elena   Krasil’nikov Mikhail  

Breast Cancer Research and Treatment, Vol. 100, Iss. 1, 2006-11 ,pp. : 1-11

Springer Publishing Company

Access to resources Recommend Favorite

Inhibition of proliferation of estrogen receptorpositive MCF7 human breast cancer cells by tamoxifen through cJun transcription factors

By                

Molecular Medicine Reports, Vol. 7, Iss. 4, 2013-01 ,pp. : 1283-1287

Spandidos Publications

Access to resources Recommend Favorite

Increased Constitutive Activity of PKB/Akt in Tamoxifen Resistant Breast Cancer MCF‐7 Cells

By Jordan Nicola J.  

Breast Cancer Research and Treatment, Vol. 87, Iss. 2, 2004-09 ,pp. : 167-180

Springer Publishing Company

Access to resources Recommend Favorite